Justice Department Recovers over $3 Billion from False Claims Act Cases in Fiscal Year 2019

DOJ press release (9 Jan 2020) on FY2019 FCA recoveries: more than $3 billion; more than $62 billion since 1986; health care $2.6 billion; relator typically 15-30%; 633 qui tam suits ("more than 12 new cases every week", average, not recorded); qui tam recoveries over $2.1 billion; $265 million to whistleblowers; seven drug makers' co-pay foundation settlements over $624 million combined; increasing use of the dismissal authority (no numbers). Named matters, none linked to a qui tam suit or relator in this release (not cases): Insys $195 million, Reckitt Benckiser $500 million civil (of $1.4 billion), Avanir over $95 million, Inform Diagnostics $63.5 million, Greenway Health over $57 million, Encompass Health $48 million, five South Korean fuel companies over $162 million, Hydro Extrusion $34.6 million, Northrop Grumman over $27 million, American Airlines $22 million, British Airways/Iberia $5.8 million, Informatica $21.57 million, Duke $112.5 million, Luke Hillier $20 million, ADS $16 million and Salle $225,000 (earlier), BCR over $3.5 million and $800,000, Omega Protein $1 million, North Greenville $2.5 million, Osteo Relief more than $7.1 million, Vanguard about $18 million allowed claims and $250,000, Diabetic Care Rx/RLH $21 million and over $300,000. Already in the data: 6 observations. Added: 2 rules, 1 observation. Decision 10 pass (2026-10-10): every named settlement, judgment and newly announced government suit not already in cases.csv added as a case with whistleblower_link=not_stated (the document does not tie it to a whistleblower): 26 cases (26 settlements). Amounts as printed (lower/upper bounds and global vs civil parts explained in notes); individuals only where named by the agency as parties.